Sharon Glied - Oct 21, 2022 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
Director
Signature
/s/ Sharon A. Glied
Stock symbol
NRXP
Transactions as of
Oct 21, 2022
Transactions value $
$0
Form type
4
Date filed
11/22/2022, 04:45 PM
Previous filing
Jun 10, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NRXP Employee Stock Option Award +163K +248.57% 228K Oct 21, 2022 Common Stock 163K $0.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options issued under the NRx Pharmaceuticals, Inc. 2021 Omnibus Incentive Plan. The options vest on May 25, 2023, generally subject to the Reporting Person's continued service for NRx Pharmaceuticals, Inc.